Skip to main content
Clinical Trials/NCT06663202
NCT06663202Not yet recruitingNot Applicable

Fibre-Retention Osseous Resective Surgery (FibReORS) Vs Conservative Surgery with or Without Papilla Preservation Technique for the Treatment of Residual Pockets: a 5-year Randomized Clinical Trial

University of Turin, Italy0 sites120 target enrollmentStarted: November 15, 2024Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Enrollment
120
Primary Endpoint
Pocket closure

Study Overview

Brief Summary

The primary aim of the study is to evaluate the efficacy of either fibre retention osseous resective surgery (FibReORS) or conservative surgery with or without PPT in the treatment of deep residual pockets ≥ 6 mm in stage III-IV periodontitis patients after cause related therapy (step II) in terms of endpoints of therapy and other secondary outcomes at different time intervals (1, 3 and 5 years). Moreover, the study aims to evaluate the stability of the results obtained for the different surgical approaches over a 5 years follow-up period.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Double (Investigator, Outcomes Assessor)

Eligibility Criteria

Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Diagnosis of stage III/IV periodontitis.
  • •Completed steps I-II periodontal therapy at least 6 weeks before.
  • •Full Mouth Plaque Score less than 15% at re-evaluation.
  • •Full Mouth Bleeding Score less than 15% at re-evaluation.
  • •Posterior sextant with residual PPD ≥ 6 mm at ≥ 2 natural teeth (third molars excluded).
  • •Signed informed consent.

Exclusion Criteria

  • •Compromised general health which contraindicates the study procedures (ASA III-VI patients).
  • •Systemic diseases/medications which could influence the outcome of the therapy (e.g. uncontrolled diabetes mellitus, non-plaque-induced gingival diseases, antiepileptic drugs (phenytoin and sodium valproate), certain calcium channel-blocking drugs (e.g., nifedipine, verapamil, diltiazem, amlodipine, felodipine), immunoregulating drugs (e.g., ciclosporine), and high-dose oral contraceptives).
  • •Pregnant or nursing women.
  • •Presence of tooth mobility ≥ class
  • •Presence of furcation involvement ≥ II degree (Hamp 1975) at the affected teeth.
  • •Presence of deep infrabony defects (≥ 3 mm) at the involved sextant.

Arms & Interventions

Fiber Retention Osseous Resective Surgery

Experimental

Paramarginal incisions both on buccal and lingual/palatal sides with bone remodelling preserving the supracrestal fibers

Intervention: Fiber retention osseous resective surgery (Procedure)

Papilla preservation flap

Active Comparator

Access flap for open flap debridement using intrasulcular incisions and papilla preservation approaches to preserve the entire interdental tissues

Intervention: Papilla preservation flap (Procedure)

Conventional surgery

Active Comparator

Access flap for open flap debridement using a conventional modified Widman flap procedure

Intervention: Widman flap procedure (Procedure)

Outcomes

Primary Outcomes

Pocket closure

Time Frame: 5 years

Defined as probing pocket depth (PPD) of 3 mm or less or PPD of 4 mm with the absence of Bleeding on Probing in sites with PPD equal or more than 6 mm at baseline.

Secondary Outcomes

  • Mean Probing Pocket Depth changes(5 Years)
  • Mean Clinical Attachment Level changes(5 years)
  • Mean recession changes(5 years)
  • Tooth Retention(5 years)
  • Number of instrumentation re-intervention(5 years)

Investigators

Sponsor
University of Turin, Italy
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Mario Aimetti

Associate Professor

University of Turin, Italy

Similar Trials